NorthAvenue LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Sell
959
-182
-16% -$48K 0.18% 26
2026
Q2
$290K Buy
1,141
+182
+19% +$42.4K 0.21% 24
2026
Q1
$234K Hold
959
– – 0.19% 23
2025
Q4
$198K Buy
+959
New +$190K 0.16% 27

Other funds holding JNJ

NorthAvenue LLC's JNJ Position: Q3 2026 in Review

NorthAvenue LLC reduced its Johnson & Johnson (JNJ) stake by 16% in Q3 2026, selling an estimated $48K and leaving 959 shares worth $254K. The position accounts for 0.18% of the portfolio, ranked #26.

NorthAvenue LLC first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. The position peaked at $290K in Q2 2026. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • NorthAvenue LLC held 959 shares of Johnson & Johnson worth $254K as of Q3 2026.
  • NorthAvenue LLC sold 182 Johnson & Johnson shares in Q3 2026, an estimated $48K.
  • Johnson & Johnson made up 0.18% of NorthAvenue LLC's portfolio in Q3 2026, its #26 holding.
  • NorthAvenue LLC first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • NorthAvenue LLC's Johnson & Johnson position peaked at $290K in Q2 2026.
  • 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on NorthAvenue LLC's 13F filing for Q3 2026, filed 29 Oct 2026.